Skip to main content
Erschienen in: Supportive Care in Cancer 3/2008

01.03.2008 | Supportive Care International

Barriers to referral to inpatient palliative care units in Japan: a qualitative survey with content analysis

verfasst von: Mitsunori Miyashita, Kei Hirai, Tatsuya Morita, Makiko Sanjo, Yosuke Uchitomi

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Objectives

We investigated the barriers to referral to inpatient palliative care units (PCUs) through a qualitative study across various sources of information, including terminal cancer patients, their families, physicians, and nurses.

Materials and methods

There were 63 participants, including 13 advanced cancer patients, 10 family members, 20 physicians, and 20 nurses in palliative care and acute care cancer settings from five regional cancer institutes in Japan. Semi-structured interviews were conducted regarding barriers to referral to PCU, and data were analyzed by content analysis method.

Results

A total of 21 barriers were identified by content analysis. The leading barriers were (1) a negative image of PCUs by patients and families (n = 39), (2) delay of termination of anti-cancer treatment by physicians in the general wards (n = 24), (3) unwillingness to end anti-cancer treatment and denial of the fatal nature of the disease by patients and families (n = 22), (4) patient’s wish to receive care from familiar physicians and nurses (n = 20), and (5) insufficient knowledge of PCUs by medical staff in general wards (n = 17).

Conclusions

To correct these unfavorable images and misconceptions of PCUs, it is important to eliminate the negative image of PCUs from the general population, patients, families, and medical staffs. In addition, early introduction of palliative care options to patients and communication skills training regarding breaking bad news are relevant issues for a smooth transition from anti-cancer treatment to palliative care.
Literatur
1.
Zurück zum Zitat Ahmed N, Bestall JC, Ahmedzai SH, Payne SA, Clark D, Noble B (2004) Systematic review of the problems and issues of accessing specialist palliative care by patients, carers and health and social care professionals. Palliat Med 18(6):525–542PubMedCrossRef Ahmed N, Bestall JC, Ahmedzai SH, Payne SA, Clark D, Noble B (2004) Systematic review of the problems and issues of accessing specialist palliative care by patients, carers and health and social care professionals. Palliat Med 18(6):525–542PubMedCrossRef
2.
Zurück zum Zitat Baile WF, Lenzi R, Parker PA, Buckman R, Cohen L (2002) Oncologists’ attitudes toward and practices in giving bad news: an exploratory study. J Clin Oncol 20(8):2189–2196PubMedCrossRef Baile WF, Lenzi R, Parker PA, Buckman R, Cohen L (2002) Oncologists’ attitudes toward and practices in giving bad news: an exploratory study. J Clin Oncol 20(8):2189–2196PubMedCrossRef
3.
Zurück zum Zitat Brickner L, Scannell K, Marquet S, Ackerson L (2004) Barriers to hospice care and referrals: survey of physicians’ knowledge, attitudes, and perceptions in a health maintenance organization. J Palliat Med 7(3):411–418PubMedCrossRef Brickner L, Scannell K, Marquet S, Ackerson L (2004) Barriers to hospice care and referrals: survey of physicians’ knowledge, attitudes, and perceptions in a health maintenance organization. J Palliat Med 7(3):411–418PubMedCrossRef
4.
Zurück zum Zitat Casarett DJ, Marenberg ME, Karlawish JH (2001) Predictors of withdrawal from hospice. J Palliat Med 4(4):491–497PubMedCrossRef Casarett DJ, Marenberg ME, Karlawish JH (2001) Predictors of withdrawal from hospice. J Palliat Med 4(4):491–497PubMedCrossRef
5.
Zurück zum Zitat Feeg VD, Elebiary H (2005) Exploratory study on end-of-life issues: barriers to palliative care and advance directives. Am J Hospice Palliat Care 22(2):119–124CrossRef Feeg VD, Elebiary H (2005) Exploratory study on end-of-life issues: barriers to palliative care and advance directives. Am J Hospice Palliat Care 22(2):119–124CrossRef
6.
Zurück zum Zitat Friedman BT, Harwood MK, Shields M (2002) Barriers and enablers to hospice referrals: an expert overview. J Palliat Med 5(1):73–84PubMedCrossRef Friedman BT, Harwood MK, Shields M (2002) Barriers and enablers to hospice referrals: an expert overview. J Palliat Med 5(1):73–84PubMedCrossRef
7.
Zurück zum Zitat Fukui S, Kawagoe H, Masako S, Noriko N, Hiroko N, Toshie M (2003) Determinants of the place of death among terminally ill cancer patients under home hospice care in Japan. Palliat Med 17(5):445–453PubMedCrossRef Fukui S, Kawagoe H, Masako S, Noriko N, Hiroko N, Toshie M (2003) Determinants of the place of death among terminally ill cancer patients under home hospice care in Japan. Palliat Med 17(5):445–453PubMedCrossRef
8.
Zurück zum Zitat Gattellari M, Voigt KJ, Butow PN, Tattersall MHN (2002) When the treatment goal is not cure: are cancer patients equipped to make informed decisions? J Clin Oncol 20(2):503–513PubMedCrossRef Gattellari M, Voigt KJ, Butow PN, Tattersall MHN (2002) When the treatment goal is not cure: are cancer patients equipped to make informed decisions? J Clin Oncol 20(2):503–513PubMedCrossRef
9.
Zurück zum Zitat Ida E, Miyachi M, Uemura M, Osakama M, Tajitsu T (2002) Current status of hospice cancer deaths both in-unit and at home (1995–2000), and prospects of home care services in Japan. Palliat Med 16(3):179–184PubMedCrossRef Ida E, Miyachi M, Uemura M, Osakama M, Tajitsu T (2002) Current status of hospice cancer deaths both in-unit and at home (1995–2000), and prospects of home care services in Japan. Palliat Med 16(3):179–184PubMedCrossRef
10.
Zurück zum Zitat Johnson CB, Slaninka SC (1999) Barriers to accessing hospice services before a late terminal stage. Death Stud 23(3):225–238PubMedCrossRef Johnson CB, Slaninka SC (1999) Barriers to accessing hospice services before a late terminal stage. Death Stud 23(3):225–238PubMedCrossRef
11.
Zurück zum Zitat Krippendorff K (1980) Content analysis: an introduction to its methodology. Sage, Beverly Hills Krippendorff K (1980) Content analysis: an introduction to its methodology. Sage, Beverly Hills
12.
Zurück zum Zitat Matsuyama R, Reddy S, Smith TJ (2006) Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 24(21):3490–3496PubMedCrossRef Matsuyama R, Reddy S, Smith TJ (2006) Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 24(21):3490–3496PubMedCrossRef
13.
Zurück zum Zitat McNeilly DP, Hillary K (1997) The hospice decision: psychosocial facilitators and barriers. Omega J Death Dying 35(2):193–217CrossRef McNeilly DP, Hillary K (1997) The hospice decision: psychosocial facilitators and barriers. Omega J Death Dying 35(2):193–217CrossRef
14.
Zurück zum Zitat Meier DE, Morrison RS, Cassel CK (1997) Improving palliative care. Ann Intern Med 127(3):225–230PubMed Meier DE, Morrison RS, Cassel CK (1997) Improving palliative care. Ann Intern Med 127(3):225–230PubMed
15.
Zurück zum Zitat Miyashita M, Sanjo M, Morita T et al (2007) Barriers to providing palliative care and priorities for future actions to advance palliative care in Japan. A nationwide expert opinion survey. J Palliat Med (in press) Miyashita M, Sanjo M, Morita T et al (2007) Barriers to providing palliative care and priorities for future actions to advance palliative care in Japan. A nationwide expert opinion survey. J Palliat Med (in press)
16.
Zurück zum Zitat Morita T, Akechi T, Ikenaga M et al (2004) Communication about the ending of anticancer treatment and transition to palliative care. Ann Oncol 15(10):1551–1557PubMedCrossRef Morita T, Akechi T, Ikenaga M et al (2004) Communication about the ending of anticancer treatment and transition to palliative care. Ann Oncol 15(10):1551–1557PubMedCrossRef
17.
Zurück zum Zitat Morita T, Akechi T, Ikenaga M et al (2005) Late referrals to specialized palliative care service in Japan. J Clin Oncol 23(12):2637–2644PubMedCrossRef Morita T, Akechi T, Ikenaga M et al (2005) Late referrals to specialized palliative care service in Japan. J Clin Oncol 23(12):2637–2644PubMedCrossRef
18.
Zurück zum Zitat Morita T, Miyashita M, Shibagaki M et al (2006) Knowledge and beliefs about end-of-life care and the effects of specialized palliative care: a population-based survey in Japan. J Pain Symptom Manage 31(4):306–316PubMedCrossRef Morita T, Miyashita M, Shibagaki M et al (2006) Knowledge and beliefs about end-of-life care and the effects of specialized palliative care: a population-based survey in Japan. J Pain Symptom Manage 31(4):306–316PubMedCrossRef
19.
Zurück zum Zitat Ogle KS, Mavis B, Wyatt GK (2002) Physicians and hospice care: attitudes, knowledge, and referrals. J Palliat Med 5(1):85–92PubMedCrossRef Ogle KS, Mavis B, Wyatt GK (2002) Physicians and hospice care: attitudes, knowledge, and referrals. J Palliat Med 5(1):85–92PubMedCrossRef
20.
Zurück zum Zitat Parker PA, Baile WF, de Moor C, Lenzi R, Kudelka AP, Cohen L (2001) Breaking bad news about cancer: patients’ preferences for communication. J Clin Oncol 19(7):2049–2056PubMed Parker PA, Baile WF, de Moor C, Lenzi R, Kudelka AP, Cohen L (2001) Breaking bad news about cancer: patients’ preferences for communication. J Clin Oncol 19(7):2049–2056PubMed
21.
Zurück zum Zitat Pugh EM (1996) An investigation of general practitioner referrals to palliative care services. Palliat Med 10(3):251–257PubMed Pugh EM (1996) An investigation of general practitioner referrals to palliative care services. Palliat Med 10(3):251–257PubMed
22.
Zurück zum Zitat Ruhnke GW, Wilson SR, Akamatsu T et al (2000) Ethical decision making and patient autonomy: a comparison of physicians and patients in Japan and the United States. Chest 118(4):1172–1182PubMedCrossRef Ruhnke GW, Wilson SR, Akamatsu T et al (2000) Ethical decision making and patient autonomy: a comparison of physicians and patients in Japan and the United States. Chest 118(4):1172–1182PubMedCrossRef
23.
Zurück zum Zitat Sanders BS, Burkett TL, Dickinson GE, Tournier RE (2004) Hospice referral decisions: the role of physicians. Am J Hospice Palliat Care 21(3):196–202CrossRef Sanders BS, Burkett TL, Dickinson GE, Tournier RE (2004) Hospice referral decisions: the role of physicians. Am J Hospice Palliat Care 21(3):196–202CrossRef
24.
Zurück zum Zitat Sanjo M, Miyashita M, Morita M, Kirai K, Akechi T, Uchitomi Y (2007) Preferences regarding end-of-life care and their association with concepts of good death: a population-based survey in Japan. Ann Oncol (in press) Sanjo M, Miyashita M, Morita M, Kirai K, Akechi T, Uchitomi Y (2007) Preferences regarding end-of-life care and their association with concepts of good death: a population-based survey in Japan. Ann Oncol (in press)
25.
Zurück zum Zitat Schockett ER, Teno JM, Miller SC, Stuart B (2005) Late referral to hospice and bereaved family member perception of quality of end-of-life care. J Pain Symptom Manage 30(5):400–407PubMedCrossRef Schockett ER, Teno JM, Miller SC, Stuart B (2005) Late referral to hospice and bereaved family member perception of quality of end-of-life care. J Pain Symptom Manage 30(5):400–407PubMedCrossRef
26.
Zurück zum Zitat Shiozaki M, Morita T, Hirai K, Sakaguchi Y, Tsuneto S, Shima Y (2005) Why are bereaved family members dissatisfied with specialised inpatient palliative care service? A nationwide qualitative study. Palliat Med 19(4):319–327PubMedCrossRef Shiozaki M, Morita T, Hirai K, Sakaguchi Y, Tsuneto S, Shima Y (2005) Why are bereaved family members dissatisfied with specialised inpatient palliative care service? A nationwide qualitative study. Palliat Med 19(4):319–327PubMedCrossRef
27.
Zurück zum Zitat Voltz R, Akabayashi A, Reese C, Ohi G, Sass HM (1997) Organization and patients’ perception of palliative care: a crosscultural comparison. Palliat Med 11(5):351–357PubMedCrossRef Voltz R, Akabayashi A, Reese C, Ohi G, Sass HM (1997) Organization and patients’ perception of palliative care: a crosscultural comparison. Palliat Med 11(5):351–357PubMedCrossRef
28.
Zurück zum Zitat Voogt E, van der Heide A, Rietjens JAC et al (2005) Attitudes of patients with incurable cancer toward medical treatment in the last phase of life. J Clin Oncol 23(9):2012–2019PubMedCrossRef Voogt E, van der Heide A, Rietjens JAC et al (2005) Attitudes of patients with incurable cancer toward medical treatment in the last phase of life. J Clin Oncol 23(9):2012–2019PubMedCrossRef
29.
Zurück zum Zitat Weggel JM (1999) Barriers to the physician decision to offer hospice as an option for terminal care. WMJ 98(3):49–53PubMed Weggel JM (1999) Barriers to the physician decision to offer hospice as an option for terminal care. WMJ 98(3):49–53PubMed
30.
Zurück zum Zitat Yabroff KR, Mandelblatt JS, Ingham J (2004) The quality of medical care at the end-of-life in the USA: existing barriers and examples of process and outcome measures. Palliat Med 18(3):202–216PubMedCrossRef Yabroff KR, Mandelblatt JS, Ingham J (2004) The quality of medical care at the end-of-life in the USA: existing barriers and examples of process and outcome measures. Palliat Med 18(3):202–216PubMedCrossRef
Metadaten
Titel
Barriers to referral to inpatient palliative care units in Japan: a qualitative survey with content analysis
verfasst von
Mitsunori Miyashita
Kei Hirai
Tatsuya Morita
Makiko Sanjo
Yosuke Uchitomi
Publikationsdatum
01.03.2008
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 3/2008
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0215-1

Weitere Artikel der Ausgabe 3/2008

Supportive Care in Cancer 3/2008 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.